Who Owns Apimeds Pharmaceuticals US, Inc (APUS)?Hedge Fund & Institutional Holders
Institutional Holders
10
as of Q4 2025
Total Institutional Value
$44957.4T
% of Float Held
—
QoQ Change in Holders
+3 / -5
Price History
APUS — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | New Position | +10 | +$0 |
| JANE STREET GROUP, LLC | New Position | +27K | +$0 |
| UBS Group AG | New Position | +582 | +$0 |
| BANK OF AMERICA CORP /DE/ | Increased | +11 | +$-52K |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | +4K | +$-54.7M |
| Hemenway Trust Co LLC | Increased | +24K | +$-444.6M |
APUS — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| Yorkville Advisors Global, LP | Closed Position | -250K | -$440.0M |
| RENAISSANCE TECHNOLOGIES LLC | Closed Position | -28K | -$49.6M |
| XTX Topco Ltd | Closed Position | -19K | -$33.3M |
| HRT FINANCIAL LP | Closed Position | -14K | -$24K |
| JPMORGAN CHASE & CO | Closed Position | -8 | -$14K |
Top Institutional Holders(Q4 2025)
| # | Fund | Shares | Value | % of Portfolio | Type |
|---|---|---|---|---|---|
| 1 | Hemenway Trust Co LLC | 274,000 | $449K | 0.03% | Share |
| 2 | VANGUARD GROUP INC | 34,953 | $57K | 0.00% | Share |
| 3 | VANGUARD GROUP INC | 24,039 | $39K | 0.00% | Share |
| 4 | JANE STREET GROUP, LLC | 27,188 | $0 | 0.00% | Share |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 32,180 | $0 | 0.00% | Share |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2,708 | $0 | 0.00% | Share |
| 7 | UBS Group AG | 582 | $0 | 0.00% | Share |
| 8 | BANK OF AMERICA CORP /DE/ | 37 | $0 | 0.00% | Share |
| 9 | BANK OF AMERICA CORP /DE/ | 3 | $0 | 0.00% | Share |
| 10 | Tower Research Capital LLC (TRC) | 10 | $0 | 0.00% | Share |
APUS Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 7 | $545K | -2 |
| Q3 2025 | 9 | $1.1B | +4 |
| Q2 2025 | 5 | $29.1M | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 10 institutional investors hold APUS (Apimeds Pharmaceuticals US, Inc). The largest holder is Hemenway Trust Co LLC with $449K in shares. This quarter, 3 institutions opened new positions and 5 closed their positions.
Frequently Asked Questions
How many hedge funds own APUS?
As of Q4 2025, 10 institutional investors report holding APUS (Apimeds Pharmaceuticals US, Inc) in their 13F filings.
Who is the largest institutional holder of APUS?
The largest institutional holder of APUS is Hemenway Trust Co LLC with $449K in shares.
Is institutional ownership of APUS increasing or decreasing?
This quarter, 3 institutions opened new positions in APUS and 5 closed their positions.